Rohto Pharmaceutical Co.,Ltd.

    Jurisdiction
    Japan
    LEI
    353800Q1CW5OS81OUM12
    ISIN
    JP3982400008 (4527.T)
    Sectors
    1. Consumer Defensive
    2. Household & Personal Products

    Scores

    Fair value (Benjamin Graham formula)
    €11.56 ∞% undervalued
    Financial strength (Piotroski F-Value)
    2 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    2 / 7

    Profile

    Rohto Pharmaceutical Co.,Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods worldwide. Read full profile

    Fundamentals

    Net revenue
    €1.71B
    Gross margin
    57.1%
    EBIT
    €213.10M
    EBIT margin
    12.5%
    Net income
    €170.90M
    Net margin
    10.0%

    Statement period: - (published )

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    Last dividend amount
    ¥21.00
    Ex date
    Payment date

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    No insider transactions in the last 90 days. View older insider transactions

    Earnings Calls

    Add to watchlist

    Notifications